臨床婦人科産科72巻5号

2018年05月発行

今月の臨床 精子・卵子保存法の現在─「産む」選択肢をあきらめないために

配偶子保存の臨床

卵子凍結

著者： 堀江昭史¹ 谷洋彦¹ 万代昌紀¹

所属機関： ¹京都大学産科婦人科

ページ範囲：P.444 - P.449

文献概要

●採卵方法 : がん患者ではその疾患特有の病態を理解し，一般不妊患者と比して若年であること，さらに採卵に伴うエストロゲン上昇などによる影響を十分考慮すべきである．

●合併症 : 若年がん患者の卵子凍結ではOHSSが有意に増加するため，注意が必要である．一方でがん治療開始までの限られた時間のなかでの採卵であるため，症例ごとの慎重な検討が求められる．

●未受精卵子の凍結 : 受精卵凍結に比べて妊娠率が低いものの，未受精卵子による妊娠・出生後の児の奇形率は増加しない．

参考文献

1）von Wolff M, et al : Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 284 : 427─435, 2011

2）Lohrisch C, et al : Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 24 : 4888─4894, 2006

3）Azim AA, et al : Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 92 : 2197─2200, 2007

4）Rodgers RJ, et al : The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer : a systematic review. Hum Reprod 32 : 1033─1045, 2017

5）Oktay K, et al : Association of BRCA1 mutations with occult primary ovarian insufficiency : a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 28 : 240─244, 2010

6）Loren AW, et al : American Society of Clinical Oncology : Fertility preservation for patients with cancer : American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31 : 2500─2510, 2013

7）Phillips KA, et al : Kathleen Cuningham Consortium for Research into Familial Breast Cancer（kConFab） : Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Hum Reprod 31 : 1126─1132, 2016

8）国立がん研究センター調べ2015 ; https://ganjoho.jp/public/index.html

9）Rodriguez-Wallberg KA, et al : Fertility preservation during cancer treatment : clinical guidelines. Cancer Manag Res 6 : 105─117, 2014

10）Hyman JH, et al : Fertility preservation options after gonadotoxic chemotherapy. Clin Med Insights Reprod Health 7 : 61─69, 2013

11）Tavares CB, et al : Expression of estrogen and progesterone receptors in astrocytomas : a literature review. Clinics（Sao Paulo） 71 : 481─486, 2016

12）González-Arenas A, et al : Estradiol increases cell growth in human astrocytoma cell lines through ER α activation and its interaction with SRC-1 and SRC-3 coactivators. Biochim Biophys Acta 1823 : 379─386, 2012

13）Glujovsky D, et al : Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database Syst Rev （9） : CD010047, 2014

14）Practice Committees of American Society for Reproductive Medicine ; Society for Assisted Reproductive Technology : Mature oocyte cryopreservation : a guideline. Fertil Steril 99 : 37─43, 2013

15）Noyes N, et al : Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 18 : 769─776, 2009

16）Cobo A, et al : Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 105 : 755─764, 2016